Chugai Pharm ADR (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,907,880 | 2,556,292 | 2,310,851 | 2,883,103 | 2,757,254 |
| Depreciation Amortization | 217,985 | 208,989 | 225,354 | 242,042 | 280,899 |
| Other Working Capital | -533,662 | -190,364 | 927,501 | -1,411,495 | -756,410 |
| Other Operating Activity | -4,127 | 379,243 | -553,238 | 166,012 | 262,854 |
| Operating Cash Flow | $2,588,076 | $2,954,160 | $2,910,468 | $1,879,662 | $2,544,597 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -646,859 | -1,151,350 | 8,925 | -583,367 | -343,370 |
| PPE Investments | -460,719 | -336,105 | -373,474 | -474,143 | -590,836 |
| Purchase Of Investment | -28,529 | -20,407 | -1,974 | -2,472 | -86,477 |
| Purchase Sale Intangibles | -236,550 | -11,121 | 91,235 | -66,328 | -62,763 |
| Other Investing Activity | -212,423 | 7,253 | 101,764 | -64,172 | -61,553 |
| Investing Cash Flow | $-1,348,529 | $-1,500,609 | $-264,759 | $-1,124,154 | $-1,082,236 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -2,006,107 | -879,443 | -934,317 | -1,064,294 | -897,660 |
| Other Financing Activity | -56,729 | -51,196 | -54,933 | -57,142 | -79,752 |
| Financing Cash Flow | $-2,062,836 | $-930,640 | $-989,250 | $-1,121,436 | $-977,413 |
| Exchange Rate Effect | 62,169 | 15,173 | 22,734 | 14,930 | 19,365 |
| Beginning Cash Position | 3,619,354 | 3,027,248 | 1,577,400 | 2,061,698 | 1,932,230 |
| End Cash Position | 2,858,233 | 3,565,333 | 3,256,585 | 1,710,701 | 2,436,552 |
| Net Cash Flow | $-761,120 | $538,085 | $1,679,186 | $-350,997 | $504,313 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,588,076 | 2,954,160 | 2,910,468 | 1,879,662 | 2,544,597 |
| Capital Expenditure | -511,029 | -332,739 | -510,831 | -482,213 | -600,318 |
| Free Cash Flow | 2,077,047 | 2,621,421 | 2,399,637 | 1,397,450 | 1,944,279 |